Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Cytokine Growth Factor Rev. 2020 Oct 6;57:39–54. doi: 10.1016/j.cytogfr.2020.09.003

Table 2. Competition for receptor binding between TGF-β family ligands.

BMP-2 BMP-4 BMP-5 BMP-6 BMP-7 BMP-9 BMP-10 Activin A Activin B Nodal GDF-5
Activin A ActRII5, 57 ActRII6 ActRII5, 9 ActRII5, 6 ActRII5
Activin B ActRII5 ActRII5
Activin C ActRII49, 55 ActRII49
GDF-8 ActRII5 ActRIIB10
GDF-11 ActRII5 ND8 ND8 ND8 ND8
GDF-3 ND177, 178
GDF-5 ALK3179, ND8 ND8 ND8
GDF-6 ND8 ND8 ND8
GDF-7 ND8
BMP-2 ND180, ActRIIB56 ActRII5 ActRII5, ND8 ActRII5, 57 ALK3179, ND8
BMP-3 ND8, 181 ActRIIB51, 56, ND8 ND8 ND8 ND8 ND8 ActRIIB51
BMP-3b ND172, 181 ND172 ND172 ND172
BMP-7 ActRIIA9
BMP-8a ND8 ND8
BMP-9 ActRII5 ActRII5
BMP-10 ActRII5, ND8 ND8 ActRII5 ActRII5
Inhibin ActRII, BMPRII54 ActRII54 ActRII54 ActRII48, 53, 182, 183 ActRII54
Lefty1 ActRII52
Lefty2 ActRII52

The table provides an overview of reported competition between TGF-β family ligands, including which receptor(s) the ligands supposedly compete for in cases where this has been investigated. The ligands listed in the first row indicate agonist ligands, whereas the ligands listed in the first column indicate ligands that compete with the agonist ligands by one of our proposed modes of competition illustrated in Figure 4. In the cells, we have indicated the receptor for which the ligands compete. ActRII: indicates ActRIIA and ActRIIB, ND: Not Determined, indicates competition for an unknown receptor. The table is likely not complete since no single literature search will cover this information.